5 Best High Risk High Reward Stocks To Buy Now

4. BridgeBio Pharma, Inc. (NASDAQ:BBIO)

Number of Hedge Fund Investors In Q2 2023: 32

Latest P/S Ratio: 771

BridgeBio Pharma, Inc. (NASDAQ:BBIO) is a biotechnology company developing treatments for children with bone growth disorders. Its shares are rated Strong Buy on average and the firm has taken on pharma giant Pfizer in developing a drug for heart condition treatments.

By the end of June 2023, 32 out of the 910 hedge funds polled by Insider Monkey had invested in BridgeBio Pharma, Inc. (NASDAQ:BBIO). Andreas Halvorsen’s Viking Global is the company’s biggest stakeholder through its $457 million stake.

Follow Bridgebio Pharma Inc. (NASDAQ:BBIO)